Ignacio Valdes M D A Professional Corporation is categorized under Medical Research in Glendale, CA and active since 2012.
Ignacio Valdes M D A Professional Corporation was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Ignacio Valdes at the company’s single location by writing to 222 West Eulalia St # 211, Glendale, California CA 91204 or by phoning (818) 502-4567. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ignacio Valdes M D A Professional Corporation |
Contact Person: | Ignacio Valdes |
Address: | 222 West Eulalia St # 211, Glendale, California 91204 |
Phone Number: | (818) 502-4567 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Ignacio Valdes M D A Professional Corporation was started in 2012 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Ignacio Valdes for inquiries that concern Ignacio Valdes M D A Professional Corporation by calling the company number (818) 502-4567, as your correspondence is most welcome. Additionally, the physical location of the single location of Ignacio Valdes M D A Professional Corporation can be found at the coordinates 34.126416,-118.256621 as well as the street address 222 West Eulalia St # 211 in Glendale, California 91204.
For its online presence, you may visit Ignacio Valdes M D A Professional Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.